Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Ciceri F"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-14 z 14
    Tytuł:
    Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT.
    Autorzy:
    Nagler A; Division of Hematology, Sheba Medical Center, Tel Hashomer, Israel. .
    Labopin M; EBMT Paris Study Office, Department of Haematology, Saint Antoine Hospital; INSERM UMR 938, Sorbonne University, Paris, France.; Department of Haematology, Saint Antoine Hospital, INSERM UMR 938, Sorbonne University, Paris, France.
    Blaise D; Programme de Transplantation and Therapie Cellulaire Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France.
    Raiola AM; Ematologia e Terapie Cellulari, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
    Corral LL; Hospital Clínico Servicio de Hematología, Salamanca, Spain.
    Bramanti S; Transplantation Unit Department of Oncology and Haematology, Istituto Clinico Humanitas, Milan, Italy.
    Sica S; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy.
    Kwon M; Hematology Hospital GU Gregorio Marañon, Instituto de Investigacion Sanitaria Gregorio Marañon, Medicina UCM, Madrid, Spain.
    Koc Y; Bone Marrow Transplant Unit, Medicana International Hospital Istanbul, Istanbuls, Turkey.
    Pavlu J; Department of Haematology, Hammersmith Hospital, Imperial College, London, UK.
    Kulagin A; Raisa Gorbacheva Memorial, Research Institute for Paediatric Oncology, Hematology, and Transplantation, First State Pavlov Medical University of St. Petersburg, St. Petersburg, Russia.
    Busca A; SSD Trapianto di Cellule Staminali, AOU Citta' Della Salute e della Scienza, Turin, Italy.
    Rodríguez AB; Hospital U. Marqués de Valdecilla, Servicio de Hematología-Hemoterapia, Santander, Spain.
    Reményi P; Dél-pesti Centrumkórház - Országos Hematológiai és Infektológiai Intézet, Department Hematology and Stem Cell Transplant, Budapest, Hungary.
    Schmid C; Department of Hematology and Oncology, Augsburg University Hospital, Augsburg, Germany.
    Brissot E; Service d'Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, AP-HP, Sorbonne University, and INSERM UMRs 938, Paris, France.
    Sanz J; Hematology Department, Hospital Universitari Politècnic La Fe, Valencia, Spain.
    Bazarbachi A; Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
    Giebel S; Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
    Ciceri F; Ospedale San Raffaele, Haematology and BMT, Milan, Italy.
    Mohty M; EBMT Paris Study Office, Department of Haematology, Saint Antoine Hospital; INSERM UMR 938, Sorbonne University, Paris, France.; Department of Haematology, Saint Antoine Hospital, INSERM UMR 938, Sorbonne University, Paris, France.
    Pokaż więcej
    Źródło:
    Journal of hematology & oncology [J Hematol Oncol] 2023 May 29; Vol. 16 (1), pp. 58. Date of Electronic Publication: 2023 May 29.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Hematopoietic Stem Cell Transplantation*/methods
    Leukemia, Myeloid, Acute*/complications
    Graft vs Host Disease*/etiology
    Adult ; Humans ; Middle Aged ; Transplantation, Haploidentical/methods ; Cyclophosphamide/therapeutic use ; Recurrence ; Transplantation Conditioning/methods ; Retrospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Similar outcomes following non-first-degree and first-degree related donor haploidentical hematopoietic cell transplantation for acute leukemia patients in complete remission: a study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Autorzy:
    Ye Y; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, China.
    Labopin M; EBMT Global Committee (Shanghai and Paris Offices) and Acute Leukemia Working Party, Hospital Saint-Antoine APHP and Sorbonne University, Paris, France.
    Chen J; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
    Gulbas Z; Anadolu Medical Center Hospital Bone Marrow Transplantation Department, Kocaeli, Turkey.
    Zhang X; Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, China.
    Koc Y; Medicana International Hospital Istanbul, Bone Marrow Transplant Unit, Istanbul, Turkey.
    Blaise D; Programme de Transplantation & Therapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France.
    Ciceri F; Ospedale San Raffaele S.R.L., Haematology and BMT, Milan, Italy.
    Polge E; EBMT Global Committee (Shanghai and Paris Offices) and Acute Leukemia Working Party, Hospital Saint-Antoine APHP and Sorbonne University, Paris, France.
    Houhou M; EBMT Global Committee (Shanghai and Paris Offices) and Acute Leukemia Working Party, Hospital Saint-Antoine APHP and Sorbonne University, Paris, France.
    Li L; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, China.
    Luo Y; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, China.
    Wu D; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
    Huang H; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, China. .
    Mohty M; EBMT Global Committee (Shanghai and Paris Offices) and Acute Leukemia Working Party, Hospital Saint-Antoine APHP and Sorbonne University, Paris, France. .; Department of Hematology and Cell Therapy, Hospital Saint-Antoine, Sorbonne University, Paris, France. .; Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, APHP, 184 rue du Faubourg Saint-Antoine, 75012, Paris, France. .
    Gorin NC; EBMT Global Committee (Shanghai and Paris Offices) and Acute Leukemia Working Party, Hospital Saint-Antoine APHP and Sorbonne University, Paris, France. .; Department of Hematology and Cell Therapy, Hospital Saint-Antoine, Sorbonne University, Paris, France. .; Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, APHP, 184 rue du Faubourg Saint-Antoine, 75012, Paris, France. .
    Pokaż więcej
    Źródło:
    Journal of hematology & oncology [J Hematol Oncol] 2023 Mar 18; Vol. 16 (1), pp. 25. Date of Electronic Publication: 2023 Mar 18.
    Typ publikacji:
    Letter; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Leukemia, Myeloid, Acute*
    Hematopoietic Stem Cell Transplantation*/adverse effects
    Graft vs Host Disease*/etiology
    Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy
    Adult ; Humans ; Bone Marrow ; Acute Disease ; Recurrence ; Retrospective Studies ; Transplantation Conditioning/adverse effects
    Raport
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMT.
    Autorzy:
    Baron F; Laboratory of Hematology, GIGA-I3, University of Liege and CHU of Liège, Sart-Tilman, 4000, Liège, Belgium. f..
    Labopin M; EBMT Paris Study Office/CEREST-TC, Paris, France.; Department of Hematology, Saint Antoine Hospital, Paris, France.; INSERM UMR 938, Paris, France.; Sorbonne University, Paris, France.
    Tischer J; Department of Internal Medicine III, LMU, University Hospital of Munich, Campus Grosshadern, Munich, Germany.
    Raiola AM; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
    Vydra J; Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
    Blaise D; Programme de Transplantation et d'immunothérapie Cellulaire, Management Sport Cancer Lab, Institut Paoli Calmettes, Aix Marseille University, Marseille, France.
    Chiusolo P; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
    Stölzel F; University Hospital Dresden, Medizinische Klinik und Poliklinik, TU Dresden, Dresden, Germany.; University Hospital Schleswig-Holstein, Kiel, Germany.
    Fanin R; Division of Hematology, Azienda Ospedaliero Universitaria di Udine, Udine, Italy.
    Chevallier P; Dept. D`Hematologie, CHU Nantes, Nantes, France.
    Nagler A; Division of Hematology and Bone Marrow Transplantation, The Chaim Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel.
    Ciceri F; Haematology and BMT, Ospedale San Raffaele S.R.L., Milan, Italy.
    Mohty M; EBMT Paris Study Office/CEREST-TC, Paris, France.; Department of Hematology, Saint Antoine Hospital, Paris, France.; INSERM UMR 938, Paris, France.; Sorbonne University, Paris, France.
    Pokaż więcej
    Źródło:
    Journal of hematology & oncology [J Hematol Oncol] 2023 Feb 13; Vol. 16 (1), pp. 10. Date of Electronic Publication: 2023 Feb 13.
    Typ publikacji:
    Letter; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Graft vs Host Disease*/etiology
    Graft vs Host Disease*/prevention & control
    Graft vs Host Disease*/drug therapy
    Leukemia, Myeloid, Acute*/drug therapy
    Hematopoietic Stem Cell Transplantation*/adverse effects
    Humans ; Transplantation, Haploidentical/adverse effects ; Unrelated Donors ; Cyclophosphamide/therapeutic use ; Recurrence ; Transplantation Conditioning/adverse effects ; Retrospective Studies
    Raport
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier.
    Autorzy:
    Oltolini C; Clinic of Infectious Diseases, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy.
    Piemontese S; Hematology and Bone Marrow Transplant, San Raffaele Scientific Institute, Milan, Italy.
    Ripa M; Clinic of Infectious Diseases, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy.; University Vita-Salute San Raffaele, Milan, Italy.
    Greco R; Hematology and Bone Marrow Transplant, San Raffaele Scientific Institute, Milan, Italy.
    Nozza S; Clinic of Infectious Diseases, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy.
    Corti C; Hematology and Bone Marrow Transplant, San Raffaele Scientific Institute, Milan, Italy.
    Peccatori J; Hematology and Bone Marrow Transplant, San Raffaele Scientific Institute, Milan, Italy.
    Scarpellini P; Clinic of Infectious Diseases, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy.
    Ciceri F; Hematology and Bone Marrow Transplant, San Raffaele Scientific Institute, Milan, Italy.; University Vita-Salute San Raffaele, Milan, Italy.
    Castagna A; Clinic of Infectious Diseases, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy.; University Vita-Salute San Raffaele, Milan, Italy.
    Pokaż więcej
    Źródło:
    Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2021 Jun; Vol. 23 (3), pp. e13551. Date of Electronic Publication: 2021 Jan 05.
    Typ publikacji:
    Letter
    MeSH Terms:
    Bone Marrow Transplantation*
    Graft vs Host Disease*
    HIV Infections*/drug therapy
    Hematologic Neoplasms*/therapy
    Cyclophosphamide/therapeutic use ; Humans ; Transplantation Conditioning
    Opinia redakcyjna
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT.
    Autorzy:
    Sanz J; Hematology Department, Hospital Universitari i Politècnic La Fe, Avinguda Fernando Abril Martorell, 106, 46026, Valencia, Spain. sanz_.; CIBERONC, Instituto Carlos III, Madrid, Spain. sanz_.
    Galimard JE; EBMT Paris Office, Hospital Saint Antoine, Paris, France.
    Labopin M; EBMT Paris Office, Hospital Saint Antoine, Paris, France.; Department of Hematology, Hopital Saint Antoine, Sorbonne University, Paris, France.
    Afanasyev B; First State Pavlov Medical University of St. Petersburg, Raisa Gorbacheva Memorial Research Institute for Paediatric Oncology, Hematology, and Transplantation, St Petersburg, Russia.
    Angelucci E; Department of Haematology, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
    Ciceri F; Haematology and BMT, Ospedale San Raffaele s.r.l., Milano, Italy.
    Blaise D; Programme de Transplantation & Therapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France.
    Cornelissen JJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
    Meijer E; Department of Hematology (Br 250), VU University Medical Center, Amsterdam, The Netherlands.
    Diez-Martin JL; Hematology Department, Hospital GU Gregorio Marañon, Instituto de Investigación sanitaria Gregorio Marañon, Universidad Complutense Madrid, Madrid, Spain.
    Koc Y; Stem Cell Transplant Unit, Medical Park Hospitals, Antalya, Turkey.
    Rovira M; Dept. of Hematology, Institute of Hematology & Oncology, Hospital Clinic, Barcelona, Spain.; Institut d'Investigació Biomèdica August Pi I Sunyer (IDIBAPS), Institut Josep Carreras, University of Barcelona, Barcelona, Spain.
    Castagna L; Transplantation Unit, Department of Oncology and Haematology, Istituto Clinico Humanitas, Milan, Italy.
    Savani B; Vanderbilt University Medical Center, Nashville, TN, USA.
    Ruggeri A; Department of Pediatric Hematology and Oncology, IRCCS Bambino Gesù Children's Hospital, Piazza S.Onofrio, 4, Rome, Italy.
    Nagler A; Division of Hematology and Bone Marrow Transplantation, The Chaim Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel.; ALWP of the EBMT office, Saint Antoine Hospital, Paris, France.
    Mohty M; Department of Hematology, Hopital Saint Antoine, Sorbonne University, Paris, France.
    Pokaż więcej
    Corporate Authors:
    Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
    Źródło:
    Journal of hematology & oncology [J Hematol Oncol] 2020 May 06; Vol. 13 (1), pp. 46. Date of Electronic Publication: 2020 May 06.
    Typ publikacji:
    Comparative Study; Journal Article
    MeSH Terms:
    Hematopoietic Stem Cell Transplantation*/adverse effects
    Cyclophosphamide/*therapeutic use
    Graft vs Host Disease/*prevention & control
    Immunosuppressive Agents/*therapeutic use
    Leukemia, Myeloid, Acute/*therapy
    Adult ; Aged ; Donor Selection ; Female ; Graft vs Host Disease/etiology ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Siblings ; Tissue Donors ; Transplantation, Haploidentical/adverse effects ; Treatment Outcome ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Haploidentical HSCT: a 15-year experience at San Raffaele.
    Autorzy:
    Bonini C; Experimental Hematology Unit, San Raffaele Scientific Institute, Milan, Italy.
    Peccatori J; Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy.
    Stanghellini MT; Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy.
    Vago L; Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy.
    Bondanza A; Experimental Hematology Unit, San Raffaele Scientific Institute, Milan, Italy.
    Cieri N; Experimental Hematology Unit, San Raffaele Scientific Institute, Milan, Italy.
    Greco R; Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy.
    Bernardi M; Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy.
    Corti C; Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy.
    Oliveira G; Experimental Hematology Unit, San Raffaele Scientific Institute, Milan, Italy.
    Zappone E; Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy.
    Traversari C; MolMed SpA, Milan, Italy.
    Bordignon C; 1] MolMed SpA, Milan, Italy [2] 'Vita-Salute' San Raffaele University, Milan, Italy.
    Ciceri F; Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy.
    Pokaż więcej
    Źródło:
    Bone marrow transplantation [Bone Marrow Transplant] 2015 Jun; Vol. 50 Suppl 2, pp. S67-71.
    Typ publikacji:
    Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Lymphocyte Transfusion*
    Graft vs Host Disease/*prevention & control
    Hematopoietic Stem Cell Transplantation/*methods
    Leukemia, Myeloid, Acute/*therapy
    Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
    T-Lymphocytes/*transplantation
    Allografts ; Female ; Genetic Engineering ; Humans ; Male
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia.
    Autorzy:
    Piemontese S; 1] Hematology and Bone Marrow Transplant Unit, San Raffaele Scientific Institute, Milan, Italy [2] EBMT Paris Office, Hosital Saint Antoine, Paris, France.
    Ciceri F; 1] Hematology and Bone Marrow Transplant Unit, San Raffaele Scientific Institute, Milan, Italy [2] EBMT Paris Office, Hosital Saint Antoine, Paris, France.
    Labopin M; 1] EBMT Paris Office, Hosital Saint Antoine, Paris, France [2] AP-HP, Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, Paris, France [3] Sorbonne Niversité, UPMC Univ Paris 06, UMR_S 938, CDR Saint-Antoine, Paris, France [4] INSERM, MR_S 938, CDR Saint-Antoine, Paris, France.
    Bacigalupo A; Division of Hematology II, IRCCS, San Martino University Hospital-IST, Genoa, Italy.
    Huang H; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
    Santarone S; Department of Hematology, Ospedale Civile, Pescara, Italy.
    Gorin NC; 1] EBMT Paris Office, Hosital Saint Antoine, Paris, France [2] AP-HP, Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, Paris, France [3] Sorbonne Niversité, UPMC Univ Paris 06, UMR_S 938, CDR Saint-Antoine, Paris, France [4] INSERM, MR_S 938, CDR Saint-Antoine, Paris, France.
    Koc Y; Hematopoietic Stem Cell Transplantation Unit, Medical Park Hospital, Antalya, Turkey.
    Wu D; The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis, Ministry of Health, Suzhou, China.
    Beelen D; Department of Bone Marrow Transplantation, University Hospital, Essen, Germany.
    Tischer J; University Hospital of Munich-Klinikum Grosshadern (LMU), Department of Internal Medicine III, Hematopoietic Cell Transplantation, Munich, Germany.
    Ehninger G; Medizinische Klinik und Poliklinik I, Universitaetsklinikum Carl Gustav Carus der TU Dresden, Dresden, Germany.
    Arcese W; Stem Cell Transplant Unit, Fondazione Policlinico Tor Vergata, Tor Vergata University, Rome, Italy.
    Nagler A; 1] EBMT Paris Office, Hosital Saint Antoine, Paris, France [2] Chaim Sheba Medical Center, Tel-Hashomer, Israel.
    Mohty M; 1] EBMT Paris Office, Hosital Saint Antoine, Paris, France [2] AP-HP, Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, Paris, France [3] Sorbonne Niversité, UPMC Univ Paris 06, UMR_S 938, CDR Saint-Antoine, Paris, France [4] INSERM, MR_S 938, CDR Saint-Antoine, Paris, France.
    Pokaż więcej
    Corporate Authors:
    Acute Leukemia Working Party (ALWP) of the European Group for Blood and Marrow Transplantation (EBMT)
    Źródło:
    Leukemia [Leukemia] 2015 May; Vol. 29 (5), pp. 1069-75. Date of Electronic Publication: 2014 Dec 01.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Graft vs Host Disease/*immunology
    Hematopoietic Stem Cell Transplantation/*methods
    Leukemia, Myeloid, Acute/*therapy
    Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
    Adolescent ; Adult ; Aged ; Alleles ; Antibodies, Monoclonal/immunology ; Disease-Free Survival ; Female ; Histocompatibility Testing ; Humans ; Leukemia, Myeloid, Acute/metabolism ; Lymphocyte Depletion ; Male ; Middle Aged ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/metabolism ; Recurrence ; Remission Induction ; Stem Cell Transplantation ; Time Factors ; Transplantation Conditioning/methods ; Transplantation, Homologous ; Treatment Outcome ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors.
    Autorzy:
    Peccatori J; Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Forcina A; 1] Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy [2] Experimental Hematology Unit, Division of Immunology, Infectious Diseases and Transplants, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Clerici D; Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Crocchiolo R; 1] Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy [2] Humanitas Cancer Center, Rozzano, Italy.
    Vago L; 1] Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy [2] Unit of Molecular and Functional Immunogenetics, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Stanghellini MT; Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Noviello M; Experimental Hematology Unit, Division of Immunology, Infectious Diseases and Transplants, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Messina C; Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Crotta A; Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Assanelli A; Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Marktel S; Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Olek S; Epiontis GmbH, Berlin, Germany.
    Mastaglio S; Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Giglio F; Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Crucitti L; Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Lorusso A; Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Guggiari E; Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Lunghi F; Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Carrabba M; Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Tassara M; Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Battaglia M; San Raffaele Diabetes Research Institute, Division of Immunology, Infectious Diseases and Transplants, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Ferraro A; San Raffaele Diabetes Research Institute, Division of Immunology, Infectious Diseases and Transplants, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Carbone MR; Experimental Hematology Unit, Division of Immunology, Infectious Diseases and Transplants, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Oliveira G; Experimental Hematology Unit, Division of Immunology, Infectious Diseases and Transplants, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Roncarolo MG; 1] Pediatric Immunology, Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy [2] San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET), Division of Regenerative Medicine, Gene Therapy and Stem Cells, San Raffaele Scientific Institute, Milan, Italy [3] 'Vita-Salute' San Raffaele University, Milan, Italy.
    Rossini S; Immunohematology and Transfusion Medicine Service, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Bernardi M; Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Corti C; Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Marcatti M; Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Patriarca F; Clinica Ematologica, Policlinico Universitario, Udine, Italy.
    Zecca M; Policlinico San Matteo, Pavia, Italy.
    Locatelli F; IRCCS Ospedale Bambino Gesù, Roma, Italy.
    Bordignon C; 1] 'Vita-Salute' San Raffaele University, Milan, Italy [2] MolMed SpA, Milan, Italy.
    Fleischhauer K; Unit of Molecular and Functional Immunogenetics, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Bondanza A; 1] Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy [2] Leukemia Immunotherapy Group, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Bonini C; Experimental Hematology Unit, Division of Immunology, Infectious Diseases and Transplants, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Ciceri F; Hematology and Bone Marrow Transplantation Unit, Division of Regenerative Medicine, Gene Therapy and Stem Cells, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Pokaż więcej
    Źródło:
    Leukemia [Leukemia] 2015 Feb; Vol. 29 (2), pp. 396-405. Date of Electronic Publication: 2014 Jun 04.
    Typ publikacji:
    Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Peripheral Blood Stem Cell Transplantation*
    Graft vs Host Disease/*immunology
    Graft vs Host Disease/*prevention & control
    HLA Antigens/*immunology
    Sirolimus/*therapeutic use
    T-Lymphocytes, Regulatory/*immunology
    Administration, Oral ; Adolescent ; Adult ; Aged ; Antibodies, Monoclonal, Murine-Derived/therapeutic use ; Antilymphocyte Serum/therapeutic use ; Blood Platelets/cytology ; Busulfan/analogs & derivatives ; Busulfan/therapeutic use ; Child ; Female ; Humans ; Immunosuppressive Agents/therapeutic use ; Male ; Middle Aged ; Mycophenolic Acid/analogs & derivatives ; Mycophenolic Acid/therapeutic use ; Neutrophils/cytology ; Prospective Studies ; Rituximab ; T-Lymphocytes/immunology ; Tissue Donors ; Transplantation Conditioning ; Treatment Outcome ; Vidarabine/analogs & derivatives ; Vidarabine/therapeutic use ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Chronic GVHD is associated with lower relapse risk irrespective of stem cell source among patients receiving transplantation from unrelated donors.
    Autorzy:
    Signori A; Department of Health Sciences (DISSAL), Section of Biostatistic, University of Genoa, Genova, Italy. />Crocchiolo R
    Oneto R
    Sacchi N
    Sormani MP
    Fagioli F
    Rambaldi A
    Ciceri F
    Bacigalupo A
    Pokaż więcej
    Źródło:
    Bone marrow transplantation [Bone Marrow Transplant] 2012 Nov; Vol. 47 (11), pp. 1474-8. Date of Electronic Publication: 2012 Apr 02.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Graft vs Host Disease/*epidemiology
    Peripheral Blood Stem Cell Transplantation/*statistics & numerical data
    Chronic Disease ; Graft vs Host Disease/mortality ; Humans ; Living Donors/statistics & numerical data ; Peripheral Blood Stem Cell Transplantation/methods ; Peripheral Blood Stem Cell Transplantation/mortality ; Recurrence ; Risk Factors ; Survival Rate ; Tissue Donors/statistics & numerical data
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Genotypes and haplotypes in the 3' untranslated region of the HLA-G gene and their association with clinical outcome of hematopoietic stem cell transplantation for beta-thalassemia.
    Autorzy:
    Sizzano F; Unit of Molecular and Functional Immunogenetics, Division of Regenerative Medicine, Stem Cells and Gene Therapy, San Raffaele Scientific Institute, Milan, Italy. />Testi M
    Zito L
    Crocchiolo R
    Troiano M
    Mazzi B
    Turchiano G
    Torchio M
    Pultrone C
    Gregori S
    Chiesa R
    Gaziev J
    Sodani P
    Marktel S
    Amoroso A
    Roncarolo MG
    Lucarelli G
    Ciceri F
    Andreani M
    Fleischhauer K
    Pokaż więcej
    Źródło:
    Tissue antigens [Tissue Antigens] 2012 May; Vol. 79 (5), pp. 326-32.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Hematopoietic Stem Cell Transplantation*
    3' Untranslated Regions/*genetics
    Graft vs Host Disease/*genetics
    HLA-G Antigens/*genetics
    beta-Thalassemia/*genetics
    3' Untranslated Regions/immunology ; Adolescent ; Adult ; Case-Control Studies ; Child ; Child, Preschool ; Female ; Genotype ; Graft vs Host Disease/diagnosis ; Graft vs Host Disease/immunology ; Haplotypes/genetics ; Haplotypes/immunology ; Humans ; Immune Tolerance ; Italy ; Linkage Disequilibrium ; Male ; Mutagenesis, Insertional ; Polymorphism, Genetic ; Sequence Deletion ; Siblings ; Transplantation, Homologous ; Treatment Outcome ; beta-Thalassemia/immunology ; beta-Thalassemia/therapy
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Progress and prospects: graft-versus-host disease.
    Autorzy:
    Mastaglio S; Hematology and BMT Unit, Department of Oncology, San Raffaele Scientific Institute, Milano, Italy.
    Stanghellini MT
    Bordignon C
    Bondanza A
    Ciceri F
    Bonini C
    Pokaż więcej
    Źródło:
    Gene therapy [Gene Ther] 2010 Nov; Vol. 17 (11), pp. 1309-17. Date of Electronic Publication: 2010 May 27.
    Typ publikacji:
    Journal Article; Review
    MeSH Terms:
    Graft vs Host Disease/*immunology
    Graft vs Host Disease/*therapy
    Animals ; Genetic Therapy ; Graft vs Host Disease/prevention & control ; Hematopoietic Stem Cell Transplantation ; Humans ; T-Lymphocytes/immunology ; Transplantation, Homologous/immunology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants.
    Autorzy:
    Bacigalupo A; Divisione Ematologia, Ospedale San Martino, Genova, Italy. />Lamparelli T
    Milone G
    Sormani MP
    Ciceri F
    Peccatori J
    Locasciulli A
    Majolino I
    Di Bartolomeo P
    Mazza F
    Sacchi N
    Pollicheni S
    Pinto V
    Van Lint MT
    Pokaż więcej
    Corporate Authors:
    Gruppo Italiano Trapianto Midollo Osseo (GITMO)
    Źródło:
    Bone marrow transplantation [Bone Marrow Transplant] 2010 Feb; Vol. 45 (2), pp. 385-91. Date of Electronic Publication: 2009 Jul 06.
    Typ publikacji:
    Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Antilymphocyte Serum/*therapeutic use
    Graft vs Host Disease/*mortality
    Hematopoietic Stem Cell Transplantation/*mortality
    Adult ; Animals ; Cause of Death ; Graft vs Host Disease/prevention & control ; Humans ; Multivariate Analysis ; Rabbits ; Recurrence ; Risk
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation.
    Autorzy:
    Ciceri F; Hematology and Cancer Immune Therapy and Gene Therapy Program, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, Italy.
    Bonini C
    Gallo-Stampino C
    Bordignon C
    Pokaż więcej
    Źródło:
    Cytotherapy [Cytotherapy] 2005; Vol. 7 (2), pp. 144-9.
    Typ publikacji:
    Journal Article; Review
    MeSH Terms:
    Genes, Transgenic, Suicide*
    Hematopoietic Stem Cell Transplantation*
    Genetic Therapy/*methods
    Graft vs Host Disease/*prevention & control
    Lymphocyte Depletion/*methods
    T-Lymphocytes/*transplantation
    Animals ; Genes, Viral ; Histocompatibility Testing ; Humans ; T-Lymphocytes/immunology ; Thymidine Kinase/genetics ; Transplantation, Homologous
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-14 z 14

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies